Long-term quality of life improvements seen in children trea

MILAN — Pediatric patients experienced improved psoriasis symptoms and quality of life with ixekizumab treatment, according to a poster presented at the European Academy of Dermatology and Venereology Congress.
“About 1% of children and adolescents worldwide are affected by plaque psoriasis (PsO),” Andreas Pinter, MD, medical director of clinical research and senior physician in

Related Keywords

Milan , Lombardia , Italy , Frankfurt , Brandenburg , Germany , Merck Serono , Andreas Pinter , Kristen Dowd , Tigercat Pharma , Byrebeccal Forand , Sanofi Genzyme , Eli Lilly , Almirall Hermal , Tanabe Pharma , Venereology Congress , Glaxosmithkline , European Academy Of Dermatology , Amgen , University Hospital Frankfurt , Boehringer Ingelheim , Schering , Novartis , Pfizer , European Academy , Merck Sharp , Mitsubishi Tanabe Pharma , Pascoe Natural Healthcare , Itch Numeric Rating Scale ,